首页> 外国专利> AN AGENT COMPRISING A NATRIURETIC PEPTIDE FOR THE TREATMENT OF ALOPECIA

AN AGENT COMPRISING A NATRIURETIC PEPTIDE FOR THE TREATMENT OF ALOPECIA

机译:包含利钠肽治疗白内障的药物

摘要

The present invention addresses the problem of providing a novel therapeutic agent for alopecia which: is safe and effective against alopecia, particularly alopecia areata, male pattern baldness in men, male pattern baldness in women, female pattern baldness, postpartum alopecia, seborrheic alopecia, alopecia pityrodes, alopecia senilis, alopecia due to chemotherapeutic agents, and alopecia due to radiation exposure; is also effective for subjects who are resistant to minoxidil and finasteride treatments; and is free of side effects such as itching, irritation and feminization, has no contraindications, reduces dandruff, has a therapeutic effect on grey hair, and has no long-term loss in therapeutic effect on alopecia even when stopped. The means for solving this problem is a therapeutic agent for alopecia that uses a C-type natriuretic peptide (CNP) or a B-type natriuretic peptide (BNP), derivatives of these natriuretic peptides (NPs), chimeric peptides of these NPs or derivatives of these NPs as active ingredients.
机译:本发明解决了提供新型脱发治疗剂的问题,该治疗剂对脱发,特别是斑秃,男性脱发,男性脱发,女性脱发,女性脱发,产后脱发,脂溢性脱发,脂溢性脱发是安全有效的。斜ity,老年性秃头症,化学治疗剂引起的秃头症和放射线照射引起的秃头症;对米诺地尔和非那雄胺治疗有抵抗力的受试者也有效;且没有瘙痒,刺激和女性化等副作用,没有禁忌症,减少头皮屑,对白发有治疗作用,即使脱发也没有长期失去治疗作用。解决该问题的方法是使用C型利钠肽(CNP)或B型利尿肽(BNP),这些利钠肽(NP)的衍生物,这些NP的嵌合肽或衍生物的脱发治疗剂。这些NP作为有效成分。

著录项

  • 公开/公告号CA2825382C

    专利类型

  • 公开/公告日2020-07-28

    原文格式PDF

  • 申请/专利权人 ENDO KYOKO;IGISU CO. LTD.;ENDO YORI;

    申请/专利号CA20122825382

  • 发明设计人 ENDO KYOKO;

    申请日2012-01-20

  • 分类号A61K38/22;A61K45;A61P17/14;A61P37/08;

  • 国家 CA

  • 入库时间 2022-08-21 11:15:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号